Safety study of JP-1366 with common heart and blood medications
Part of Heart & circulation clinical trials.
This trial tests how a new drug, JP-1366, interacts with several common heart and blood medications (clopidogrel, aspirin, atorvastatin, and apixaban) in healthy volunteers. It aims to see if the combination is safe and how the drugs affect each other in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 19 and 64 years old
- Weigh at least 50 kg (or 45 kg for women) and have a BMI between 18 and 30
- Be in good general health without significant medical conditions
- No history of bleeding disorders or gastrointestinal diseases/surgeries that could affect drug absorption
- No hereditary conditions like galactose intolerance or lactose deficiency
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called JP-1366 to see if it can prevent stomach ulcers caused by long-term NSAID use (like ibuprofen or naproxen) for conditions such as arthritis. It may be a good fit if you need to take NSAIDs for at least 24 weeks and have a higher risk of ulcers.
This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This early-phase study tests a new drug in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
This trial tests a new medicine, JP-1366, for people with non-erosive GERD (heartburn and acid reflux without visible damage to the esophagus). The goal is to see if it helps control symptoms better than a placebo.
This is an early-stage safety study testing a new drug called JPH034 in healthy volunteers. Researchers want to see how the drug is tolerated and what happens to it in your body.
Hear when a new Drug Drug Interaction (DDI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.